Former Promoters Of Ranbaxy Told To Disclose Asset Details
LIVELAW NEWS NETWORK
6 March 2017 10:13 PM IST
Justice Muralidhar of the Delhi High Court has asked former promoters of Ranbaxy Laboratories Ltd to disclose details of their assets.The direction comes in a foreign arbitration case in which Japanese company Daiichi Sankyo has sought to restrain the formers promoters - Malvinder Singh and Shivender Singh - from selling their assets.A Singapore-based arbitration tribunal had ruled...
This is a premium content
Available exclusively to
Our subscribers
Subscribe Premium 
INR 1099+GST
Your support helps us to bring you more content at
an affordable subscription scheme !!!
All payment options available
Justice Muralidhar of the Delhi High Court has asked former promoters of Ranbaxy Laboratories Ltd to disclose details of their assets.
The direction comes in a foreign arbitration case in which Japanese company Daiichi Sankyo has sought to restrain the formers promoters - Malvinder Singh and Shivender Singh - from selling their assets.
A Singapore-based arbitration tribunal had ruled against Ranbaxy Laboratories Ltd and the award required Ranbaxy to pay over ₹2,500 crore to Daiichi.
Daiichi was represented by senior counsel CA Sundaram.
He said the Singh brothers might be looking for investors for selling off their stake in Fortis Healthcare.
In 2008, Daiichi had bought a majority stake in Ranbaxy for $4.6 billion. But a few months later, they alleged that certain crucial information was hidden from them during the sale and initiated arbitration proceedings.
